Cutera, Inc. (NASDAQ:CUTR) Short Interest Update

Cutera, Inc. (NASDAQ:CUTR) was the target of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 4,400,000 shares, a growth of 8.9% from the November 15th total of 4,040,000 shares. Based on an average daily trading volume, of 290,700 shares, the days-to-cover ratio is presently 15.1 days.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Cutera in a report on Thursday, December 12th. They issued a “sell” rating on the stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Squarepoint Ops LLC grew its holdings in Cutera by 164.5% during the second quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after purchasing an additional 70,870 shares during the period. Bank of Montreal Can increased its holdings in shares of Cutera by 14.2% during the 2nd quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock worth $455,000 after acquiring an additional 35,248 shares during the last quarter. Finally, Ground Swell Capital LLC bought a new stake in Cutera in the 2nd quarter valued at $37,000. Institutional investors own 90.70% of the company’s stock.

Cutera Price Performance

Shares of Cutera stock traded up $0.00 on Tuesday, hitting $0.36. The company had a trading volume of 23,398 shares, compared to its average volume of 854,002. The stock has a 50-day moving average of $0.51 and a 200-day moving average of $0.96. Cutera has a twelve month low of $0.28 and a twelve month high of $4.97. The firm has a market capitalization of $7.17 million, a P/E ratio of -0.05 and a beta of 1.26.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.